Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
alpha galactosidase (PRX-102)
print preview
bookmark
share with colleague
General Information
Company
Protalix BioTherapeutics Inc.
Description
Plant cell-expressed recombinant form of human alpha galactosidase A
Molecular Target
Alpha galactosidase A
Mechanism of Action
Enzyme replacement therapy
Latest Stage of Development
Phase I/II
Indication
Fabry's disease
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy